ICU MEDICAL INC (ICUI) Stock Fundamental Analysis
USA - NASDAQ:ICUI - US44930G1076 - Common Stock
134.33 USD
+1.76 (+1.33%)
134.33 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to ICUI. ICUI was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ICUI has an average financial health and profitability rating. ICUI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
ICUI had a positive operating cash flow in the past year.
In multiple years ICUI reported negative net income over the last 5 years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
ICUI's Return On Assets of -0.90% is fine compared to the rest of the industry. ICUI outperforms 72.34% of its industry peers.
With a decent Return On Equity value of -1.75%, ICUI is doing good in the industry, outperforming 71.81% of the companies in the same industry.
ICUI's Return On Invested Capital of 2.81% is fine compared to the rest of the industry. ICUI outperforms 70.21% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ICUI is significantly below the industry average of 8.98%.
The 3 year average ROIC (1.36%) for ICUI is below the current ROIC(2.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.75% | ||
| ROIC | 2.81% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
The Operating Margin of ICUI (5.43%) is better than 70.21% of its industry peers.
ICUI's Operating Margin has declined in the last couple of years.
ICUI has a Gross Margin of 35.84%. This is in the lower half of the industry: ICUI underperforms 70.21% of its industry peers.
In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.43% | ||
| PM (TTM) | N/A | ||
| GM | 35.84% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
Compared to 1 year ago, ICUI has more shares outstanding
ICUI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ICUI is higher compared to a year ago.
2.2 Solvency
ICUI has an Altman-Z score of 2.11. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.11, ICUI is in the better half of the industry, outperforming 62.77% of the companies in the same industry.
ICUI has a debt to FCF ratio of 26.58. This is a negative value and a sign of low solvency as ICUI would need 26.58 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 26.58, ICUI is doing good in the industry, outperforming 68.62% of the companies in the same industry.
ICUI has a Debt/Equity ratio of 0.63. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, ICUI is not doing good in the industry: 65.96% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 26.58 | ||
| Altman-Z | 2.11 |
ROIC/WACC0.37
WACC7.51%
2.3 Liquidity
A Current Ratio of 2.44 indicates that ICUI has no problem at all paying its short term obligations.
ICUI has a Current ratio (2.44) which is comparable to the rest of the industry.
ICUI has a Quick Ratio of 1.17. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ICUI (1.17) is worse than 70.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.14% over the past year.
The Earnings Per Share has been decreasing by -5.28% on average over the past years.
The Revenue has been growing slightly by 5.44% in the past year.
Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
3.2 Future
The Earnings Per Share is expected to grow by 17.18% on average over the next years. This is quite good.
Based on estimates for the next years, ICUI will show a small growth in Revenue. The Revenue will grow by 1.96% on average per year.
EPS Next Y14.6%
EPS Next 2Y14.9%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.96%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ICUI is valuated correctly with a Price/Earnings ratio of 16.88.
83.51% of the companies in the same industry are more expensive than ICUI, based on the Price/Earnings ratio.
ICUI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.07.
A Price/Forward Earnings ratio of 16.36 indicates a correct valuation of ICUI.
Based on the Price/Forward Earnings ratio, ICUI is valued cheaply inside the industry as 82.98% of the companies are valued more expensively.
ICUI is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.08, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.88 | ||
| Fwd PE | 16.36 |
4.2 Price Multiples
ICUI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ICUI is cheaper than 84.04% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICUI indicates a somewhat cheap valuation: ICUI is cheaper than 71.28% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 65.66 | ||
| EV/EBITDA | 12.82 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ICUI's earnings are expected to grow with 15.91% in the coming years.
PEG (NY)1.16
PEG (5Y)N/A
EPS Next 2Y14.9%
EPS Next 3Y15.92%
5. Dividend
5.1 Amount
No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
134.33
+1.76 (+1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners113.8%
Inst Owner Change3.94%
Ins Owners0.98%
Ins Owner Change-1.8%
Market Cap3.32B
Revenue(TTM)2.38B
Net Income(TTM)-36.95M
Analysts83.33
Price Target177.68 (32.27%)
Short Float %6.31%
Short Ratio5.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.5%
Min EPS beat(2)31.74%
Max EPS beat(2)37.25%
EPS beat(4)4
Avg EPS beat(4)33.31%
Min EPS beat(4)24.67%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)30.18%
EPS beat(12)12
Avg EPS beat(12)24.5%
EPS beat(16)15
Avg EPS beat(16)18.53%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.09%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-0.01%
Revenue beat(12)6
Avg Revenue beat(12)-0.81%
Revenue beat(16)8
Avg Revenue beat(16)-0.38%
PT rev (1m)-2.02%
PT rev (3m)-7.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)0%
EPS NY rev (3m)5.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.88 | ||
| Fwd PE | 16.36 | ||
| P/S | 1.4 | ||
| P/FCF | 65.66 | ||
| P/OCF | 23.89 | ||
| P/B | 1.57 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.82 |
EPS(TTM)7.96
EY5.93%
EPS(NY)8.21
Fwd EY6.11%
FCF(TTM)2.05
FCFY1.52%
OCF(TTM)5.62
OCFY4.19%
SpS96.09
BVpS85.69
TBVpS-3.41
PEG (NY)1.16
PEG (5Y)N/A
Graham Number123.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.75% | ||
| ROCE | 3.56% | ||
| ROIC | 2.81% | ||
| ROICexc | 3.06% | ||
| ROICexgc | 9.06% | ||
| OM | 5.43% | ||
| PM (TTM) | N/A | ||
| GM | 35.84% | ||
| FCFM | 2.13% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 26.58 | ||
| Debt/EBITDA | 3.98 | ||
| Cap/Depr | 42.51% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 41.23% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.11 |
F-Score7
WACC7.51%
ROIC/WACC0.37
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y14.6%
EPS Next 2Y14.9%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.96%
EBIT growth 1Y118.78%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year37.73%
EBIT Next 3Y15.54%
EBIT Next 5Y10.05%
FCF growth 1Y216.11%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y243.63%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
What is the valuation status of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
How profitable is ICU MEDICAL INC (ICUI) stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 14.6% in the next year.